Exchange: OTC·Updated 02:23 PM EDT
PXMD logo

PXMD PaxMedica, Inc.

$0.0007
$0.00
(0.00%)
Today
Reported EarningsNov 29
Mkt Cap$88,385.00
Vol2.00

About PXMD

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
42

Bearish Sentiment

How do you feel about PXMD?

Advertisement|Remove ads.